AtriCure, Inc. (ATRC) is a publicly traded Healthcare sector company. As of September 10, 2026, ATRC trades at $52.98 with a market cap of $2.73B and a P/E ratio of 241.36. ATRC moved -0.21% today. Year to date, ATRC is +34.05%; over the trailing twelve months it is +46.86%. Its 52-week range spans $25.36 to $55.72. Analyst consensus is strong buy with an average price target of $52.86. Rallies surfaces ATRC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ATRC combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $52.98 |
| Market Cap | $2.73B |
| P/E Ratio | 241.36 |
| EPS | $0.22 |
| Dividend Yield | 0.00% |
| 52-Week High | $55.72 |
| 52-Week Low | $25.36 |
| Volume | 143.58K |
| Avg Volume | 0 |
| Revenue (TTM) | $569.62M |
| Net Income | $10.55M |
| Gross Margin | 76.30% |
8 analysts cover ATRC: 0 strong buy, 6 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $52.86.